NAP alpha-aminoisobutyric acid (IsoNAP). (Q50693898)

17 March 2018

title

NAP alpha-aminoisobutyric acid (IsoNAP). (English)

1 reference

17 March 2018

author name string

Illana Gozes

1

1 reference

17 March 2018

Yulie Schirer

2

1 reference

17 March 2018

Anat Idan-Feldman

3

1 reference

17 March 2018

Merav David

4

1 reference

17 March 2018

Sharon Furman-Assaf

5

1 reference

17 March 2018

publication date

1 January 2014

1 reference

17 March 2018

Journal of Molecular Neuroscience

published in

1 reference

17 March 2018

volume

52

1 reference

17 March 2018

page(s)

1-9

1 reference

17 March 2018

issue

1

1 reference

17 March 2018

https://scigraph.springernature.com/pub.10.1007/s12031-013-0103-8

exact match

0 references

cites work

The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

The use of the Morris Water Maze in the study of memory and learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

Protective peptides that are orally active and mechanistically nonchiral

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

A femtomolar acting octapeptide interacts with tubulin and protects astrocytes against zinc intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

Inhibition of amyloid fibril formation by peptide analogues modified with alpha-aminoisobutyric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

NAP (davunetide) provides functional and structural neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

NAP: research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: protection against impairments in axonal transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

D-NAP prophylactic treatment in the SOD mutant mouse model of amyotrophic lateral sclerosis: review of discovery and treatment of tauopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse--a microtubule-deficient model of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

Developments of a water-maze procedure for studying spatial learning in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

The ADNP derived peptide, NAP modulates the tubulin pool: implication for neurotrophic and neuroprotective activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

The role of the VQIVYK peptide in tau protein phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

Activity-dependent neuroprotective protein: a novel gene essential for brain formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

NAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

Strategies for diminishing katanin-based loss of microtubules in tauopathic neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

Differential effects of ethanol antagonism and neuroprotection in peptide fragment NAPVSIPQ prevention of ethanol-induced developmental toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

A novel peptide prevents death in enriched neuronal cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

A Neuronal Microtubule-Interacting Agent, NAPVSIPQ, Reduces Tau Pathology and Enhances Cognitive Function in a Mouse Model of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0103-8

Tau and caspase 3 as targets for neuroprotection

21 January 2018

1 reference

12 December 2020

Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy

1 reference

12 December 2020

NAP and D-SAL: neuroprotection against the beta amyloid peptide (1-42)

1 reference

12 December 2020

Experimental models of head trauma

1 reference

12 December 2020

Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer's disease at early pathological stage

1 reference

12 December 2020

Sexual dimorphism of activity-dependent neuroprotective protein in the mouse arcuate nucleus

1 reference

12 December 2020

Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze.

1 reference

12 December 2020

10.1007/S12031-013-0103-8

Identifiers

DOI

1 reference

17 March 2018

PubMed ID

24458740

1 reference

17 March 2018